Representative Jonathan L. Jackson (D-Illinois) recently sold shares of McKesson Corporation (NYSE:MCK). In a filing disclosed on November 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in McKesson stock on October 8th. The trade occurred in the Representative’s “MORGAN STANLEY IRA” account.
Representative Jonathan L. Jackson also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of Shopify (NASDAQ:SHOP) on 10/8/2025.
- Purchased $15,001 – $50,000 in shares of Robinhood Markets (NASDAQ:HOOD) on 10/8/2025.
- Purchased $15,001 – $50,000 in shares of Shopify (NASDAQ:SHOP) on 10/6/2025.
- Purchased $1,001 – $15,000 in shares of Robinhood Markets (NASDAQ:HOOD) on 9/5/2025.
- Purchased $1,001 – $15,000 in shares of Tenet Healthcare (NYSE:THC) on 9/3/2025.
- Sold $1,001 – $15,000 in shares of Lam Research (NASDAQ:LRCX) on 9/3/2025.
- Sold $1,001 – $15,000 in shares of ARM (NASDAQ:ARM) on 9/2/2025.
- Purchased $15,001 – $50,000 in shares of Doximity (NASDAQ:DOCS) on 8/25/2025.
- Sold $1,001 – $15,000 in shares of International Business Machines (NYSE:IBM) on 8/13/2025.
- Purchased $1,001 – $15,000 in shares of Lam Research (NASDAQ:LRCX) on 8/13/2025.
McKesson Stock Performance
Shares of McKesson stock opened at $855.78 on Wednesday. The stock has a market cap of $106.44 billion, a price-to-earnings ratio of 34.12, a price-to-earnings-growth ratio of 1.46 and a beta of 0.51. The stock has a 50 day moving average price of $764.28 and a 200-day moving average price of $726.81. McKesson Corporation has a one year low of $558.13 and a one year high of $867.63.
McKesson Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be given a dividend of $0.82 per share. The ex-dividend date is Monday, December 1st. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s dividend payout ratio is 10.21%.
Institutional Trading of McKesson
A number of large investors have recently modified their holdings of MCK. GGM Financials LLC bought a new stake in McKesson during the 3rd quarter valued at $25,000. Solstein Capital LLC grew its position in shares of McKesson by 171.4% during the 2nd quarter. Solstein Capital LLC now owns 38 shares of the company’s stock worth $28,000 after buying an additional 24 shares in the last quarter. Bank of Jackson Hole Trust increased its stake in shares of McKesson by 64.3% during the first quarter. Bank of Jackson Hole Trust now owns 46 shares of the company’s stock valued at $29,000 after buying an additional 18 shares during the period. State of Wyoming purchased a new stake in McKesson in the second quarter worth about $29,000. Finally, CBIZ Investment Advisory Services LLC increased its position in McKesson by 1,366.7% during the 1st quarter. CBIZ Investment Advisory Services LLC now owns 44 shares of the company’s stock valued at $30,000 after purchasing an additional 41 shares during the period. Hedge funds and other institutional investors own 85.07% of the company’s stock.
Insider Activity at McKesson
In other McKesson news, CEO Brian S. Tyler sold 11,930 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $705.63, for a total transaction of $8,418,165.90. Following the sale, the chief executive officer owned 4,012 shares of the company’s stock, valued at approximately $2,830,987.56. This trade represents a 74.83% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the business’s stock in a transaction on Friday, November 7th. The stock was sold at an average price of $861.63, for a total value of $283,476.27. Following the completion of the transaction, the chief accounting officer directly owned 328 shares of the company’s stock, valued at approximately $282,614.64. The trade was a 50.08% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 24,189 shares of company stock worth $16,787,319. 0.08% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
MCK has been the subject of a number of recent analyst reports. Evercore ISI reaffirmed an “outperform” rating and set a $1,000.00 price target on shares of McKesson in a research note on Thursday, November 6th. Citigroup raised their price objective on shares of McKesson from $820.00 to $860.00 and gave the stock a “buy” rating in a research note on Wednesday, September 24th. TD Cowen upped their target price on McKesson from $830.00 to $864.00 and gave the company a “buy” rating in a research note on Wednesday, September 24th. Jefferies Financial Group raised their price target on McKesson from $820.00 to $900.00 and gave the stock a “buy” rating in a research note on Monday, October 13th. Finally, Wall Street Zen cut McKesson from a “buy” rating to a “hold” rating in a report on Saturday. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, McKesson presently has an average rating of “Moderate Buy” and an average price target of $887.69.
About Representative Jackson
Jonathan Jackson (Democratic Party) is a member of the U.S. House, representing Illinois’ 1st Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.
Jackson (Democratic Party) is running for re-election to the U.S. House to represent Illinois’ 1st Congressional District. He declared candidacy for the 2026 election.
Jonathan Jackson was born in Chicago, Illinois. Jackson graduated from Whitney Young High School. He earned an M.B.A. from Northwestern University. Jackson’s career experience includes working as an investment analyst and an entrepreneur.
About McKesson
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Further Reading
- Five stocks we like better than McKesson
- Why is the Ex-Dividend Date Significant to Investors?
- Amazon Is One of the Clearest Buys If the Market Dips Again
- Are Penny Stocks a Good Fit for Your Portfolio?
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- What is Insider Trading? What You Can Learn from Insider Trading
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
